Toxoplasma is an obligate intracellular parasite that can cause serious disease in immunocompromised patients and in the developing fetus. The majority of Toxoplasma isolates from human patients and livestock in Europe and North-America belong to one of three genetically distinct strains, the type I, type II and type III strains. In mice, these three distinct strains differ enormously in virulence and other phenotypes and there is good evidence that in humans this is also the case. Understanding how these distinct Toxoplasma strains differ in causing disease has important clinical implications;some strains may cause disease through over-stimulation of the immune response leading to toxic levels of cytokines while other strains may cause disease mainly through tissue damage caused by the large numbers of parasites present. If it was known how distinct Toxoplasma strains cause disease and with what strain a patient was infected the treatment could be matched to the specifics of the infection;in some cases inhibition of the immune response might be the best choice while in other cases aggressive treatment with anti-parasitic agents might be needed. Our hypothesis is that, besides host and environmental factors, the genotype of the Toxoplasma strain plays a major role in determining disease outcome through differences between strains in modulating host cell signaling pathways. The goal of this grant is therefore the identification and characterization of Toxoplasma gene products involved in strain-specific modulation of host cell signaling pathways. We will first determine differences between virulent and avirulent strains of Toxoplasma in modulating signaling pathways in mouse innate immune cells in vivo. We will then use existing F1 progeny from crosses between these strains to map the Toxoplasma genomic regions involved. Subsequently, we will use molecular genetic approached to identify the Toxoplasma genes involved. Finally, we will characterize the mechanism of action of these genes. The ability to co-opt host signaling pathways for the parasite's own purposes is likely to be found in other Apicomplexa that are also living within a membrane-limited vacuole, for example, Plasmodium species as they grow within hepatocytes. It is therefore expected that a thorough understanding of the mechanisms Toxoplasma uses to modulate host cell signaling will lead to better therapies against this and other Apicomplexan parasites.

Public Health Relevance

Toxoplasma is an obligate intracellular parasite that can cause serious disease in immunocompromised patients and in the developing fetus. It is expected that the results of this grant will lead to a thorough understanding of the mechanisms Toxoplasma uses to modulate host cell signaling. This could lead to better therapies against this and other Apicomplexan parasites.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI080621-05
Application #
8497573
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Wali, Tonu M
Project Start
2009-07-10
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
5
Fiscal Year
2013
Total Cost
$379,935
Indirect Cost
$149,611
Name
Massachusetts Institute of Technology
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Gorfu, Gezahegn; Cirelli, Kimberly M; Melo, Mariane B et al. (2014) Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii. MBio 5:
Camejo, Ana; Gold, Daniel A; Lu, Diana et al. (2014) Identification of three novel Toxoplasma gondii rhoptry proteins. Int J Parasitol 44:147-60
Hassan, Musa A; Butty, Vincent; Jensen, Kirk D C et al. (2014) The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages. Genome Res 24:377-89
Hassan, Musa A; Saeij, Jeroen P J (2014) Incorporating alternative splicing and mRNA editing into the genetic analysis of complex traits. Bioessays 36:1032-40
Cannella, Dominique; Brenier-Pinchart, Marie-Pierre; Braun, Laurence et al. (2014) miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain. Cell Rep 6:928-37
Cirelli, Kimberly M; Gorfu, Gezahegn; Hassan, Musa A et al. (2014) Inflammasome sensor NLRP1 controls rat macrophage susceptibility to Toxoplasma gondii. PLoS Pathog 10:e1003927
Lim, Daniel; Gold, Daniel A; Julien, Lindsay et al. (2013) Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence. J Biol Chem 288:34968-80
Yang, Ninghan; Farrell, Andrew; Niedelman, Wendy et al. (2013) Genetic basis for phenotypic differences between different Toxoplasma gondii type I strains. BMC Genomics 14:467
Rosowski, Emily E; Nguyen, Quynh P; Camejo, Ana et al. (2013) Toxoplasma gondii inhibits IFN-ýý- and IFN-*-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA. Infect Immun :
Niedelman, Wendy; Sprokholt, Joris K; Clough, Barbara et al. (2013) Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication. Infect Immun 81:4341-9

Showing the most recent 10 out of 16 publications